New details about the way this important molecule takes on tasks beyond sensing calcium could spur the develop of new drugs for breast cancer and other diseases.
BeatProfiler, a new research tool invented by Columbia bioengineers with the help of AI, speeds and simplifies the analysis of engineered heart tissue in the laboratory.
Columbia neuroscientists have identified a genetic mutation that fends off Alzheimer's in people at high risk and could lead to a new way to protect people from the disease.
Columbia researchers have uncovered an array of new genes that cause stillbirth, significantly increasing the understanding of the genetic foundations of a common, but little studied, condition.
New genetic and patient analyses suggest severe COVID is linked to overactive complement, one of the immune system’s oldest branches, and excess blood clotting.
Columbia's Irving Institute for Clinical and Translational Research selected five new Herbert and Florence Irving Scholars to receive funding for the next three years to support their research.
Physicians, researchers, and public health experts from Columbia University weigh in on what we now know about the novel coronavirus and what we still need to learn.
Columbia researchers have isolated antibodies from COVID-19 patients that neutralize SARS-CoV-2 virus and could be used to treat patients or prevent infections.
The health of donated human lungs judged too poor for transplantation can be recovered using a cross-circulation technique designed by biomedical engineers at Columbia University.
With high precision, a new algorithm predicts which patients treated for traumatic injuries in the emergency department will later develop post-traumatic stress disorder.
New eye drops could prevent vision loss after retinal vein occlusion, a major cause of blindness for millions of adults, a study by Columbia University researchers has found.